T. Rowe Price leads financing of med device maker Kardium

Kardium Inc, a Burnaby, British Columbia-based medical device company, has raised undisclosed financing led by T. Rowe Price Associates, a U.S. investment management firm. The round was joined by new and existing investors. Kardium, founded in 2007, has developed an advanced system for the diagnosis and treatment of atrial fibrillation, a heart rhythm disorder. Led by CEO Doug Goertzen, the company will use the funds raised to commercialize the system in Canada and Europe and back clinical testing in the United States.